Costanera, Hepolito F.
HRN: 14-01-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2024
CO-AMOXICLAV 625MG (TAB)
04/26/2024
05/02/2024
PO
625mg
TID
Soft Tissue Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes